Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation

Saved in:
Bibliographic Details
Published in:PeerJ
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030190980562944
collection WordPress RSS
FRELIP Feed Integration
container_title PeerJ
description
discipline_display Multidisciplinary
discipline_facet Multidisciplinary
format Online Article
RSS Article
genre Journal Article
id rss_article:8900
institution FRELIP
journal_source_facet PeerJ
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
Multidisciplinary
General
Multidisciplinary
sub_discipline_display General
sub_discipline_facet General
subject_display Multidisciplinary
General
Multidisciplinary
Multidisciplinary
General
Multidisciplinary
subject_facet Multidisciplinary
General
Multidisciplinary
title Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
title_auth Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
title_full Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
title_fullStr Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
title_full_unstemmed Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
title_short Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
title_sort poly(adp-ribose) polymerase (parp) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation
topic Multidisciplinary
General
Multidisciplinary
url https://peerj.com/articles/20842